Myomo (MYO) Change in Inventory (2016 - 2025)
Myomo (MYO) posted Change in Inventory of -$185864.0 for Q3 2025, down 128.42% on a QoQ basis from $653968.0 in Q2 2025, and down 124.55% year-over-year from $757138.0 in Q3 2024.
Myomo (MYO) Change in Inventory (2016 - 2025) Analysis & Trends
Myomo's Change in Inventory history runs 10 years deep, the most recent figure standing at -$185864.0 for Q3 2025.
- Quarterly Change in Inventory fell 124.55% year-over-year to -$185864.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $840725.0 (down 54.99% YoY) and the FY2024 annual result came in at $1.4 million, up 262.55% from the prior year.
- Change in Inventory was -$185864.0 for Q3 2025 at Myomo, down from $653968.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $757138.0 in Q3 2024 and bottomed at -$226055.0 in Q2 2023.
- A 5-year average of $185490.6 and a median of $170956.0 in 2021 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory tumbled 200.04% — and 2022, when it soared 556.23%.
- Myomo's Change in Inventory stood at $170956.0 in 2021, then slumped by 185.0% to -$145320.0 in 2022, then jumped by 302.78% to $294681.0 in 2023, then slumped by 160.46% to -$178151.0 in 2024, then fell by 4.33% to -$185864.0 in 2025.
- Business Quant data shows MYO's Change in Inventory at -$185864.0 in Q3 2025, $653968.0 in Q2 2025, and $550772.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -185,864.00 |
| Sep 30, 2025 | -185,864.00 |
| Jun 30, 2025 | 653,968.00 |
| Jun 30, 2025 | 653,968.00 |
| Mar 31, 2025 | 550,772.00 |
| Mar 31, 2025 | 550,772.00 |
| Dec 31, 2024 | -178,151.00 |
| Dec 31, 2024 | -178,151.00 |
| Sep 30, 2024 | 757,138.00 |
| Sep 30, 2024 | 757,138.00 |
| Jun 30, 2024 | 218,968.00 |
| Jun 30, 2024 | 218,968.00 |
| Mar 31, 2024 | 597,087.00 |
| Mar 31, 2024 | 597,087.00 |
| Dec 31, 2023 | 294,681.00 |
| Dec 31, 2023 | 294,681.00 |
| Sep 30, 2023 | 159,007.00 |
| Sep 30, 2023 | 159,007.00 |
| Jun 30, 2023 | -226,055.00 |
| Jun 30, 2023 | -226,055.00 |